Development guidelines for MAbs serve as a blueprint for their manufacture, safety, and efficacy testing.
Gisela Cálas
Advertisement
Articles by Gisela Cálas
Advertisement
Latest Updated Articles
GMP Compliance for Production of CB.Hep-1 Monoclonal Antibody as a Biological ReagentPublished: February 1st 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
3
Everything to Know About Cell and Gene Therapy in 2025
4
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
5
